PLMA_1170x120_7-2-21

oseltamivir phosphate capsules

Lupin cleared to market generic Tamiflu suspension

Lupin cleared to market generic Tamiflu suspension

BALTIMORE — Lupin Pharmaceuticals Inc., the U.S. arm of India-based Lupin Ltd., has received Food and Drug Administration approval for oseltamivir phosphate oral suspension 6 mg (base)/ml, a flu medication. Lupin said its oseltamivir oral suspension product, set to roll out soon, is a generic version of Tamiflu oral suspension (6 mg/ml) from Hoffman-La Roche Inc. Oseltamivir phosphate oral suspension is indicated

Amneal releases Tamiflu generic

Amneal releases Tamiflu generic

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has launched oseltamivir phosphate capsules, an antiviral medication used to treat symptoms of influenza. Amneal said its oseltamivir phosphate product, a generic version of Tamiflu from Genentech, comes in dosages of 30 mg, 45 mg and 75 mg. Each strength is available in 10-count blister dose packs. Manufactured in Amneal’s recently expanded